Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECAP-Rx: Clinical Pharmacy Services in Renal Impairment
NCT07241494Completed
- Sponsor
- Istanbul University-Cerrahpaşa
- Start
- Oct 2021
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by Istanbul University-Cerrahpaşa. Primary endpoint: Change in the number of drug-related problems (DRPs) per patient at 12 months. Started Oct 2021; status: completed.
Beyond the preview
Go deeper on NCT07241494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07241494.